319 related articles for article (PubMed ID: 36247234)
1. Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions.
Norouzi Masir M; Shirvaliloo M
JGH Open; 2022 Aug; 6(10):667-76. PubMed ID: 36247234
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
[TBL] [Abstract][Full Text] [Related]
3. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
4. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
Viruses; 2023 May; 15(6):. PubMed ID: 37376531
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
[TBL] [Abstract][Full Text] [Related]
7. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Damage, Inflammation and Microbiota Alteration during COVID-19 Infection.
Saviano A; Brigida M; Petruzziello C; Zanza C; Candelli M; Morabito Loprete MR; Saleem F; Ojetti V
Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189632
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.
Galanopoulos M; Gkeros F; Doukatas A; Karianakis G; Pontas C; Tsoukalas N; Viazis N; Liatsos C; Mantzaris GJ
World J Gastroenterol; 2020 Aug; 26(31):4579-4588. PubMed ID: 32884218
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus disease 2019 and the gut-lung axis.
Zhou D; Wang Q; Liu H
Int J Infect Dis; 2021 Dec; 113():300-307. PubMed ID: 34517046
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
12. Implications of SARS-CoV-2 infection for neurogastroenterology.
Marasco G; Lenti MV; Cremon C; Barbaro MR; Stanghellini V; Di Sabatino A; Barbara G
Neurogastroenterol Motil; 2021 Mar; 33(3):e14104. PubMed ID: 33591607
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19.
Zhang J; Garrett S; Sun J
Genes Dis; 2021 Jul; 8(4):385-400. PubMed ID: 33521210
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).
Sherif ZA; Gomez CR; Connors TJ; Henrich TJ; Reeves WB;
Elife; 2023 Mar; 12():. PubMed ID: 36947108
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for growth hormone replacement in adults to control acute and post-acute COVID-19?
Venugopal N; Armstrong PA; Wright TJ; Randolph KM; Batson RD; Yuen KCJ; Masel B; Sheffield-Moore M; Pyles RB; Urban RJ
Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101842. PubMed ID: 37996257
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-associated diarrhea.
Megyeri K; Dernovics Á; Al-Luhaibi ZII; Rosztóczy A
World J Gastroenterol; 2021 Jun; 27(23):3208-3222. PubMed ID: 34163106
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 - gastrointestinal and gut microbiota-related aspects.
Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
[TBL] [Abstract][Full Text] [Related]
20. Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges.
Suryana KD; Simadibrata M; Renaldi K
Acta Med Indones; 2021 Jan; 53(1):96-104. PubMed ID: 33818412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]